These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12422620)

  • 1. Bone lesions in malignant diseases--I. Current concepts of major pathogenetic mechanisms and forms.
    Goranov SE; Simeonov SB
    Folia Med (Plovdiv); 2002; 44(1-2):7-14. PubMed ID: 12422620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of the spectrum of skeletal complications of neoplasia.
    Goltzman D; Karaplis AC; Kremer R; Rabbani SA
    Cancer; 2000 Jun; 88(12 Suppl):2903-8. PubMed ID: 10898332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radiological and histological changes in the skeleton in systemic haematological diseases (author's transl)].
    Kessler M; Bartl R; Küffer G
    Rofo; 1980 Mar; 132(3):301-8. PubMed ID: 6448787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone metastasis: histological changes and pathophysiological mechanisms in osteolytic or osteosclerotic localizations. A review.
    Chappard D; Bouvard B; Baslé MF; Legrand E; Audran M
    Morphologie; 2011 Jun; 95(309):65-75. PubMed ID: 21620753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diffuse bone lesions in chronic pancreatitis].
    Epiney J; Périat M
    Rev Rhum Mal Osteoartic; 1976 Mar; 43(3):213-6. PubMed ID: 1265416
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evolution of bone lesions in repeated hemodialysis].
    Meyrier A; Marsac J; Billard D; Richet G
    Ann Med Interne (Paris); 1973 Feb; 124(2):85-90. PubMed ID: 4723746
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pathophysiology of bone metastases].
    Chappard D; Legrand E; Massin P; Basle MF; Audran M
    Prog Urol; 2003 Apr; 13(2 Suppl 1):9-17. PubMed ID: 12815804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone lesions in malignant diseases--II. Therapeutic management.
    Goranov SE; Simeonov SB
    Folia Med (Plovdiv); 2002; 44(1-2):15-21. PubMed ID: 12422621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacologic therapy of bone tissue changes due to hematologic malignancies and bone metastasis].
    Kiełbiński M
    Acta Haematol Pol; 1994; 25(2):91-8. PubMed ID: 8067192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone.
    Clines GA; Guise TA
    Endocr Relat Cancer; 2005 Sep; 12(3):549-83. PubMed ID: 16172192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathophysiology of bone metastases and new molecular targets involved in bone remodelling].
    Clézardin P
    Bull Cancer; 2013 Nov; 100(11):1083-91. PubMed ID: 24152978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.
    Guise TA; Yin JJ; Taylor SD; Kumagai Y; Dallas M; Boyce BF; Yoneda T; Mundy GR
    J Clin Invest; 1996 Oct; 98(7):1544-9. PubMed ID: 8833902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D deficiency promotes growth of MCF-7 human breast cancer in a rodent model of osteosclerotic bone metastasis.
    Ooi LL; Zheng Y; Zhou H; Trivedi T; Conigrave AD; Seibel MJ; Dunstan CR
    Bone; 2010 Oct; 47(4):795-803. PubMed ID: 20638491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone disease in maintenance hemodialysis. Clinical, biochemical and radiological correlates].
    Luño J; García de Vinuesa MS; Alles A; Jofre R; López JM; Barril G; Olivas E; Valderrábano F
    Rev Clin Esp; 1981 Jan; 160(2):91-6. PubMed ID: 7209063
    [No Abstract]   [Full Text] [Related]  

  • 15. Extending preclinical models of skeletal manifestations of malignancy to the clinical setting.
    Goltzman D
    Semin Oncol; 2001 Aug; 28(4 Suppl 11):9-14. PubMed ID: 11544570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Destructive bone lesions in primary amyloidosis.
    Kramer MR; van Dijk JM; Hadas I; Hershko C
    Postgrad Med J; 1986 Nov; 62(733):1037-41. PubMed ID: 3628150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone metastases and tumor-induced hypercalcemia.
    Body JJ
    Curr Opin Oncol; 1992 Aug; 4(4):624-31. PubMed ID: 1511019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dialysis osteodystrophy. A study involving 94 patients.
    Chan YL; Furlong TJ; Cornish CJ; Posen S
    Medicine (Baltimore); 1985 Sep; 64(5):296-309. PubMed ID: 3839891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone Pain and Muscle Weakness in Cancer Patients.
    Milgrom DP; Lad NL; Koniaris LG; Zimmers TA
    Curr Osteoporos Rep; 2017 Apr; 15(2):76-87. PubMed ID: 28497213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone turnover and biochemical markers in malignancy.
    Kanis JA; McCloskey EV
    Cancer; 1997 Oct; 80(8 Suppl):1538-45. PubMed ID: 9362420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.